Literature DB >> 24356537

Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.

In-Uk Song1, Yong-An Chung, Sung-Woo Chung, Jaeseung Jeong.   

Abstract

BACKGROUND: Since patterns of cognitive dysfunction in mild Parkinson's disease associated with dementia (PDD) are similar to those in mild Alzheimer's disease (AD), it is difficult to accurately differentiate between these two types of dementia in their early phases using neuropsychological tests. The purpose of the current study was to investigate differences in cerebral perfusion patterns of patients with AD and PDD at the earliest stages using single photon emission computed tomography (SPECT).
METHODS: We consecutively recruited 31 patients with mild PDD, 32 patients with mild probable AD and 33 age-matched healthy subjects. All subjects underwent (99m)Tc-hexamethylpropyleneamine oxime perfusion SPECT and completed general neuropsychological tests.
RESULTS: We found that both mild PDD and AD patients showed distinct hypoperfusion in frontal, parietal and temporal regions, compared with healthy subjects. More importantly, hypoperfusion in occipital and cerebellar regions was observed only in mild PDD.
CONCLUSION: The observation of a significant decrease in cerebral perfusion in occipital and cerebellar regions in patients with mild PDD is likely useful to differentiate between PDD and AD at the earliest stages.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24356537     DOI: 10.1159/000357128

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  5 in total

1.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

2.  Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.

Authors:  Gemma Cuberas-Borrós; Isabel Roca; Joan Castell-Conesa; Laura Núñez; Mercè Boada; Oscar L López; Carlota Grifols; Miquel Barceló; Deborah Pareto; Antonio Páez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-22       Impact factor: 10.057

3.  A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging.

Authors:  Won-Jin Moon; Ju-Yeon Park; Won-Sung Yun; Ji Yeong Jeon; Yeon Sil Moon; Heejin Kim; Ki-Chang Kwak; Jong-Min Lee; Seol-Heui Han
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

4.  Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.

Authors:  Lina Cheng; Xiaoyan Wu; Ruomi Guo; Yuzhou Wang; Wensheng Wang; Peng He; Hanbo Lin; Jun Shen
Journal:  BMC Med Imaging       Date:  2020-07-13       Impact factor: 1.930

5.  Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.

Authors:  Gemma Cuberas-Borrós; Isabel Roca; Mercè Boada; Lluís Tárraga; Isabel Hernández; Mar Buendia; Lourdes Rubio; Gustavo Torres; Ángel Bittini; Juan A Guzmán-de-Villoria; Francesc Pujadas; Mireia Torres; Laura Núñez; Joan Castell; Antonio Páez
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.